276 related articles for article (PubMed ID: 27448919)
1. Discovery of novel Tetrahydrobenzo[b]thiophene and pyrrole based scaffolds as potent and selective CB2 receptor ligands: The structural elements controlling binding affinity, selectivity and functionality.
Osman NA; Ligresti A; Klein CD; Allarà M; Rabbito A; Di Marzo V; Abouzid KA; Abadi AH
Eur J Med Chem; 2016 Oct; 122():619-634. PubMed ID: 27448919
[TBL] [Abstract][Full Text] [Related]
2. Tricyclic pyrazoles part 7. Discovery of potent and selective dihydrothienocyclopentapyrazole derived CB2 ligands.
Pinna G; Curzu MM; Dore A; Lazzari P; Ruiu S; Pau A; Murineddu G; Pinna GA
Eur J Med Chem; 2014 Oct; 85():747-57. PubMed ID: 25134064
[TBL] [Abstract][Full Text] [Related]
3. Tricyclic pyrazoles. Part 8. Synthesis, biological evaluation and modelling of tricyclic pyrazole carboxamides as potential CB2 receptor ligands with antagonist/inverse agonist properties.
Deiana V; Gómez-Cañas M; Pazos MR; Fernández-Ruiz J; Asproni B; Cichero E; Fossa P; Muñoz E; Deligia F; Murineddu G; García-Arencibia M; Pinna GA
Eur J Med Chem; 2016 Apr; 112():66-80. PubMed ID: 26890113
[TBL] [Abstract][Full Text] [Related]
4. 7-Azaindolequinuclidinones (7-AIQD): A novel class of cannabinoid 1 (CB1) and cannabinoid 2 (CB2) receptor ligands.
Penthala NR; Shoeib A; Dachavaram SS; Cabanlong CV; Yang J; Zhan CG; Prather PL; Crooks PA
Bioorg Med Chem Lett; 2020 Nov; 30(22):127501. PubMed ID: 32882418
[TBL] [Abstract][Full Text] [Related]
5. 1,2-Dihydro-2-oxopyridine-3-carboxamides: the C-5 substituent is responsible for functionality switch at CB2 cannabinoid receptor.
Lucchesi V; Parkkari T; Savinainen JR; Malfitano AM; Allarà M; Bertini S; Castelli F; Del Carlo S; Laezza C; Ligresti A; Saccomanni G; Bifulco M; Di Marzo V; Macchia M; Manera C
Eur J Med Chem; 2014 Mar; 74():524-32. PubMed ID: 24518874
[TBL] [Abstract][Full Text] [Related]
6. Systematic Modification of the Substitution Pattern of the 7-Hydroxy-5-oxopyrazolo[4,3-
Mugnaini C; Kostrzewa M; Casini M; Kumar P; Catallo V; Allarà M; Guastaferro L; Brizzi A; Paolino M; Tafi A; Kapatais C; Giorgi G; Vacondio F; Mor M; Corelli F; Ligresti A
Molecules; 2023 Jun; 28(13):. PubMed ID: 37446625
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, biological activity and molecular modeling of new biphenylic carboxamides as potent and selective CB2 receptor ligands.
Bertini S; Parkkari T; Savinainen JR; Arena C; Saccomanni G; Saguto S; Ligresti A; Allarà M; Bruno A; Marinelli L; Di Marzo V; Novellino E; Manera C; Macchia M
Eur J Med Chem; 2015 Jan; 90():526-36. PubMed ID: 25486424
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and binding studies of new potent ligands of cannabinoid receptors.
Brizzi A; Brizzi V; Cascio MG; Bisogno T; Sirianni R; Di Marzo V
J Med Chem; 2005 Nov; 48(23):7343-50. PubMed ID: 16279794
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands.
Showalter VM; Compton DR; Martin BR; Abood ME
J Pharmacol Exp Ther; 1996 Sep; 278(3):989-99. PubMed ID: 8819477
[TBL] [Abstract][Full Text] [Related]
10. Three-dimensional quantitative structure-selectivity relationships analysis guided rational design of a highly selective ligand for the cannabinoid receptor 2.
Brogi S; Corelli F; Di Marzo V; Ligresti A; Mugnaini C; Pasquini S; Tafi A
Eur J Med Chem; 2011 Feb; 46(2):547-55. PubMed ID: 21183257
[TBL] [Abstract][Full Text] [Related]
11. Functional Selectivity of CB2 Cannabinoid Receptor Ligands at a Canonical and Noncanonical Pathway.
Dhopeshwarkar A; Mackie K
J Pharmacol Exp Ther; 2016 Aug; 358(2):342-51. PubMed ID: 27194477
[TBL] [Abstract][Full Text] [Related]
12. Rational design, synthesis and anti-proliferative properties of new CB2 selective cannabinoid receptor ligands: an investigation of the 1,8-naphthyridin-2(1H)-one scaffold.
Manera C; Saccomanni G; Malfitano AM; Bertini S; Castelli F; Laezza C; Ligresti A; Lucchesi V; Tuccinardi T; Rizzolio F; Bifulco M; Di Marzo V; Giordano A; Macchia M; Martinelli A
Eur J Med Chem; 2012 Jun; 52():284-94. PubMed ID: 22483967
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and pharmacological evaluation of new biphenylic derivatives as CB2 receptor ligands.
Bertini S; Chicca A; Arena C; Chicca S; Saccomanni G; Gertsch J; Manera C; Macchia M
Eur J Med Chem; 2016 Jun; 116():252-266. PubMed ID: 27078864
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and biological evaluation of novel alkenylthiophenes as potent and selective CB1 cannabinoid receptor antagonists.
Tai CL; Hung MS; Pawar VD; Tseng SL; Song JS; Hsieh WP; Chiu HH; Wu HC; Hsieh MT; Kuo CW; Hsieh CC; Tsao JP; Chao YS; Shia KS
Org Biomol Chem; 2008 Feb; 6(3):447-50. PubMed ID: 18219411
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, cannabinoid receptor affinity, molecular modeling studies and in vivo pharmacological evaluation of new substituted 1-aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamides. 2. Effect of the 3-carboxamide substituent on the affinity and selectivity profile.
Silvestri R; Ligresti A; La Regina G; Piscitelli F; Gatti V; Brizzi A; Pasquini S; Lavecchia A; Allarà M; Fantini N; Carai MA; Novellino E; Colombo G; Di Marzo V; Corelli F
Bioorg Med Chem; 2009 Aug; 17(15):5549-64. PubMed ID: 19595596
[TBL] [Abstract][Full Text] [Related]
16. Mastering tricyclic ring systems for desirable functional cannabinoid activity.
Petrov RR; Knight L; Chen SR; Wager-Miller J; McDaniel SW; Diaz F; Barth F; Pan HL; Mackie K; Cavasotto CN; Diaz P
Eur J Med Chem; 2013 Nov; 69():881-907. PubMed ID: 24125850
[TBL] [Abstract][Full Text] [Related]
17. Benzofuran and pyrrole derivatives as cannabinoid receptor modulators with
Wadea NE; Issac MM; Osman NA; Abadi AH
Future Med Chem; 2019 Dec; 11(24):3139-3159. PubMed ID: 31838898
[No Abstract] [Full Text] [Related]
18. Synthesis, binding assays, cytotoxic activity and docking studies of benzimidazole and benzothiophene derivatives with selective affinity for the CB2 cannabinoid receptor.
Romero-Parra J; Mella-Raipán J; Palmieri V; Allarà M; Torres MJ; Pessoa-Mahana H; Iturriaga-Vásquez P; Escobar R; Faúndez M; Di Marzo V; Pessoa-Mahana CD
Eur J Med Chem; 2016 Nov; 124():17-35. PubMed ID: 27560280
[TBL] [Abstract][Full Text] [Related]
19. C3-heteroaroyl cannabinoids as photolabeling ligands for the CB2 cannabinoid receptor.
Dixon DD; Tius MA; Thakur GA; Zhou H; Bowman AL; Shukla VG; Peng Y; Makriyannis A
Bioorg Med Chem Lett; 2012 Aug; 22(16):5322-5. PubMed ID: 22796181
[TBL] [Abstract][Full Text] [Related]
20. The tamoxifen derivative ridaifen-B is a high affinity selective CB
Franks LN; Ford BM; Fujiwara T; Zhao H; Prather PL
Toxicol Appl Pharmacol; 2018 Aug; 353():31-42. PubMed ID: 29906493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
